Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,668,470 | N/A | 6,761,370 | 3,695,210 | 7,664,580 |
| Marketable Securities | 0 | N/A | 2,307,150 | 1,907,500 | 1,866,520 |
| Receivables | 10,165,820 | N/A | 10,995,490 | 9,799,230 | 9,738,700 |
| Inventories | 6,363,810 | N/A | 6,127,060 | 4,491,390 | 3,964,310 |
| Other current assets | 314,760 | 144,690 | 1,074,550 | 364,920 | 761,200 |
| TOTAL | $27,512,860 | $144,690 | $27,265,620 | $20,258,250 | $23,995,310 |
| Non-Current Assets | |||||
| PPE Net | 14,678,740 | N/A | 15,649,820 | 12,771,990 | 12,113,290 |
| Investments And Advances | 2,112,390 | 2,109,130 | 1,692,840 | 1,356,440 | 1,161,790 |
| Other Non-Current Assets | 22,813,580 | 20,978,190 | 17,428,690 | 12,707,470 | 12,257,130 |
| TOTAL | $39,604,710 | $23,087,320 | $34,771,350 | $26,835,900 | $25,532,210 |
| Total Assets | $67,117,600 | $23,232,010 | $62,037,000 | $47,094,170 | $49,527,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,604,270 | 11,269,120 | 9,726,860 | 8,977,250 | 9,372,680 |
| Accrued Expenses | 2,272,120 | 1,446,900 | 1,652,820 | 1,144,500 | 0 |
| Other current liabilities | 3,795,740 | 4,092,130 | 2,309,150 | 1,944,360 | 1,629,790 |
| TOTAL | $18,975,570 | $18,581,530 | $20,700,340 | $13,389,390 | $17,319,530 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,153,390 | N/A | 14,141,060 | 8,794,790 | 9,598,490 |
| Other Non-Current Liabilities | 8,311,780 | 9,484,610 | 6,205,090 | 6,514,990 | 8,260,040 |
| TOTAL | $32,475,170 | $10,809,080 | $22,121,030 | $16,406,360 | $18,894,670 |
| Total Liabilities | $51,450,770 | $29,390,610 | $42,821,400 | $29,795,780 | $36,214,220 |
| Shareholders' Equity | |||||
| Common Shares | 2,217,310 | 2,624,820 | 3,007,500 | 2,760,810 | 2,715,110 |
| Retained earnings | 9,898,050 | N/A | 13,674,830 | 12,956,290 | 10,159,350 |
| Other shareholders' equity | 1,409,310 | 717,880 | 10 | 0 | 438,870 |
| TOTAL | $15,666,820 | $5,802,430 | $19,215,600 | $17,298,390 | $13,313,330 |
| Total Liabilities And Equity | $67,117,590 | $35,193,040 | $62,037,000 | $47,094,170 | $49,527,550 |